Home NDC 82829-002 IZERVAY
Product NDC 82829-002
11-digit product format 828290002
Labeler code 82829
Product ID 82829-002_7eb1c0ad-51ef-4edd-9f71-558f4e53b07c
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name avacincaptad pegol
Dosage form INJECTION
Route INTRAVITREAL
Labeler Astellas Pharma US, Inc.
Application NDA217225
Marketing category NDA
Marketing start 2023-08-19
Substance AVACINCAPTAD PEGOL SODIUM
Active strength 20 mg/mL
Pharmacologic classes Complement Inhibitor [EPC], Complement Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217225-001 IZERVAY AVACINCAPTAD PEGOL SODIUM EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04
Orange Book patents# Current patent rows page 1 of 1 · 6 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N217225-001 8236773 2026-11-11 U-3673 2023-08-31 N217225-001 7579456 2027-02-14 Drug substance 2023-08-31 N217225-001 9617546 2027-02-14 U-3673 Drug substance 2023-08-31 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 N217225-001 11491176 2034-07-11 U-3673 2023-08-31 N217225-001 12016875 2034-07-11 U-3673 2024-10-01
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 84e616aacf4f…2026-08-18 06:07:40 2026-07 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 9b2671bbb829…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217225-001 IZERVAY EQ 2MG BASE/0.1ML (EQ 2MG BASE/0.1ML) SOLUTION / INTRAVITREAL RLD, RS 2023-08-04 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 5 · 176 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N217225-001 8236773 2026-11-11 U-3673 2023-08-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217225-001 7579456 2027-02-14 Drug substance 2023-08-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217225-001 9617546 2027-02-14 U-3673 Drug substance 2023-08-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217225-001 11491176 2034-07-11 U-3673 2023-08-31 84e616aacf4f…2026-09-14 22:38:34 2026-08 N217225-001 12016875 2034-07-11 U-3673 2024-10-01 84e616aacf4f…2026-08-18 06:07:40 2026-07 N217225-001 8236773 2026-11-11 U-3673 2023-08-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217225-001 7579456 2027-02-14 Drug substance 2023-08-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217225-001 9617546 2027-02-14 U-3673 Drug substance 2023-08-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217225-001 11491176 2034-07-11 U-3673 2023-08-31 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217225-001 12016875 2034-07-11 U-3673 2024-10-01 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N217225-001 8236773 2026-11-11 U-3673 2023-08-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217225-001 7579456 2027-02-14 Drug substance 2023-08-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217225-001 9617546 2027-02-14 U-3673 Drug substance 2023-08-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217225-001 11491176 2034-07-11 U-3673 2023-08-31 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217225-001 12016875 2034-07-11 U-3673 2024-10-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 10947544 2025-02-14 U-3673 Drug substance 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 7538211 2025-02-14 Drug substance 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 7803931 2025-02-14 Drug substance 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 7579456 2026-02-14 Drug substance 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 9617546 2026-02-14 U-3673 Drug substance 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 8236773 2026-11-11 U-3673 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 11491176 2034-07-11 U-3673 2023-08-31 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217225-001 12016875 2034-07-11 U-3673 2024-10-01 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217225-001 10947544 2025-02-14 U-3673 Drug substance 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 7538211 2025-02-14 Drug substance 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 7803931 2025-02-14 Drug substance 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 7579456 2026-02-14 Drug substance 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 9617546 2026-02-14 U-3673 Drug substance 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 8236773 2026-11-11 U-3673 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 11273171 2034-07-11 U-3673 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 11491176 2034-07-11 U-3673 2023-08-31 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217225-001 12016875 2034-07-11 U-3673 2024-10-01 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 10947544 2025-02-14 U-3673 Drug substance 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 7538211 2025-02-14 Drug substance 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 7803931 2025-02-14 Drug substance 2023-08-31 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217225-001 7579456 2026-02-14 Drug substance 2023-08-31 fd3edfee7708…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base IZERVAY
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength AVACINCAPTAD PEGOL SODIUM 20 mg/mL
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 82829-002-01 IZERVAY 0.35 mL in 1 VIAL, SINGLE-DOSE INJECTION 0.35 9 82829-002-01 IZERVAY 1 in 1 CARTON INJECTION 1 9 82829-002-99 IZERVAY 1 in 1 CARTON INJECTION 1 9 82829-002-99 IZERVAY 0.35 mL in 1 VIAL, SINGLE-DOSE INJECTION 0.35 9
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 82829-002 IZERVAY (AVACINCAPTAD PEGOL) INJECTION [ASTELLAS PHARMA US, INC.] 8 Current NDC, 4 package rows 20250316_1642fe6a-dc26-4d20-ae6e-654af744e3bd.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 82829-002-01 82829000201 1 VIAL, SINGLE-DOSE in 1 CARTON (82829-002-01) / .35 mL in 1 VIAL, SINGLE-DOSE 2023-08-19 No No Current 82829-002-99 82829000299 1 VIAL, SINGLE-DOSE in 1 CARTON (82829-002-99) / .35 mL in 1 VIAL, SINGLE-DOSE 2023-08-19 Yes No Current